This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1981-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1984
Title: Anton Fliri: Innovator in Biochemical Synthesis
Introduction
Anton Fliri is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemical synthesis, particularly in the production of imidazolidone intermediates. With a total of 3 patents to his name, Fliri's work has implications for the synthesis of essential compounds like biotin.
Latest Patents
Fliri's latest patents include a process for producing imidazolidone intermediates from 2H-chromene. This innovative method is crucial for synthesizing biotin, a vital nutrient. Another patent details a similar process, emphasizing the importance of these intermediates in biochemical applications.
Career Highlights
Fliri is currently employed at Hoffmann-La Roche Inc., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to collaborate with other experts in the field, further enhancing his contributions to biochemical innovation.
Collaborations
One of his notable coworkers is Kraft Hohenlohe-Oehringen, with whom he has likely shared insights and expertise in their respective areas of research.
Conclusion
Anton Fliri's innovative work in the synthesis of biotin intermediates showcases his significant role in the field of biochemistry. His patents reflect a commitment to advancing scientific knowledge and practical applications in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile